Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
akouos
3
×
biotech
boston blog main
clinical trials
life sciences
national blog main
san francisco blog main
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer
deals
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
investing
national
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
sickle cell disease
texas blog main
texas top stories
venture capital
vir biotechnology
wisconsin blog main
wisconsin top stories
abbvie
abeona therapeutics
accent therapeutics
What
bio
drug
ipo
medicines
plans
roundup
acquisitions
advantages
affects
americans
announced
approved
bar
brings
ceo
collabs
covid
daniel
date
deal
developing
expect
fda
frequency
gamble
gilead
gilead’s
hearing
help
introduce
loss
market
medco’s
meds
millions
month
mover
new
o’day
patients
Language
unset
Current search:
akouos
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone